Skip to content

Andreas Schiermeyer

  • Fraunhofer Institute for Molecular Biology and Applied Ecology
  • 11h-indexImpact measure calculated using publication and citation counts. Updated daily.
  • 330CitationsNumber of citations received by Andreas's publications. Updated daily.

Research interests

Plant biotechnologyGenetic engineeringPlant-made pharmaceuticalsPlant suspension cell cultureGene targetingProteolysisPlant molecular farming

Co-authors (62)

  • Kaloian Nickolov

Publications (5)

  • The levels of peroxisomal catalase protein and activity modulate the onset of cell death in tobacco BY-2 cells via reactive oxygen species levels and autophagy

    • Tyutereva E
    • Dobryakova K
    • Schiermeyer A
    • et al.
    N/AReaders
    N/ACitations
    Get full text
  • Plant Molecular Pharming, Pharmaceuticals for Human Health plant molecular pharming pharmaceuticals for human health

    • Schiermeyer A
    • Schillberg S
    N/AReaders
    N/ACitations
    Get full text
  • Plant Molecular Pharming, Pharmaceuticals for Human Health plant molecular pharming pharmaceuticals for human health

    • Schiermeyer A
    • Schillberg S
    N/AReaders
    N/ACitations
    Get full text
  • Pharmaceuticals

    • Kempken F
    • Lorz H
    • Nagata T
    • et al.
    N/AReaders
    N/ACitations
    Get full text
  • Proteases reduce recombinant protein yields in transgenic plant suspension cells

    • Dorfmueller S
    • Hartenstein H
    • Schiermeyer A
    • et al.
    N/AReaders
    N/ACitations

Professional experience

Fraunhofer Institute for Molecular Biology and Applied Ecology